Copyright
©2013 Baishideng Publishing Group Co.
World J Gastroenterol. Feb 14, 2013; 19(6): 855-865
Published online Feb 14, 2013. doi: 10.3748/wjg.v19.i6.855
Published online Feb 14, 2013. doi: 10.3748/wjg.v19.i6.855
Figure 4 A 62-year-old male patient with hepatocellular carcinoma.
Two months after percutaneous ethanol ablation for hepatocellular carcinoma in segment 8 of the liver. A, B: The false positive local tumor progression (arrow) was detected. It showed rim-like hyperenhancement in the arterial phase, wash-out in the portal-late phase on contrast-enhanced ultrasound; C, D: On contrast-enhanced computed tomography, the treated area (arrow) showed complete necrosis without any enhancement in all the vascular phases, but several enhanced hepatic vessels around the treated area.
- Citation: Zheng SG, Xu HX, Lu MD, Xie XY, Xu ZF, Liu GJ, Liu LN. Role of contrast-enhanced ultrasound in follow-up assessment after ablation for hepatocellular carcinoma. World J Gastroenterol 2013; 19(6): 855-865
- URL: https://www.wjgnet.com/1007-9327/full/v19/i6/855.htm
- DOI: https://dx.doi.org/10.3748/wjg.v19.i6.855